chronic obstructive lung disease; coronavirus disease 2019; coughing; disease burden; disease severity; drug efficacy; drug safety; dyspnea; editorial; human; interstitial lung disease; lung disease; non insulin dependent diabetes mellitus; pandemic; prognosis; quality of life; respiratory tract allergy; SARS coronavirus; scientific literature; shared decision making; sleep disordered breathing; smoking; subcutaneous emphysema; systemic sclerosis; tobacco; corticosteroid; dupilumab; muscarinic receptor; nintedanib; inhaler; chronic rhinosinusitis with nasal polyps